• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国老年人按年龄组划分的哮喘患病率:年龄仍然很重要。

Asthma prevalence among US elderly by age groups: age still matters.

作者信息

Oraka Emeka, Kim Huyi Jin Elizabeth, King Michael E, Callahan David B

机构信息

Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30324, USA.

出版信息

J Asthma. 2012 Aug;49(6):593-9. doi: 10.3109/02770903.2012.684252. Epub 2012 Jul 6.

DOI:10.3109/02770903.2012.684252
PMID:22765313
Abstract

OBJECTIVE

For over three decades, the greatest burden of asthma deaths has occurred among persons aged 65 years and older. This study analyzed the association between increasing age and asthma prevalence among age groups within the US elderly population.

METHODS

We analyzed aggregated data on 54,485 civilian, noninstitutionalized US adults aged 65 years and older from the 2001-2010 National Health Interview Survey (NHIS). We estimated the prevalence of current asthma, lifetime asthma, and chronic obstructive pulmonary disease (COPD) among US elderly by 5-year age groups and age stages ("young elderly" aged 65-84 years and "oldest old" aged ≥85 years). We calculated adjusted odds ratios (AOR) and 95% confidence intervals (CI) to identify asthma prevalence patterns among elderly populations.

RESULTS

From 2001 to 2010, the estimated average annual prevalence of current asthma among US elderly was 7.0%. Estimates of lifetime asthma, COPD, and co-occurring current asthma and COPD were 9.9%, 9.7%, and 3.0%, respectively. Prevalence of asthma decreased with advancing age while prevalence of COPD increased with advancing age. When controlling for study variables and significant interactions (p = .05) with COPD, the odds of reporting current asthma decreased with advancing age: 0.87 (95% CI, 0.76-1.01) for 70- to 74-year-olds; 0.76 (95% CI, 0.66-0.87) for 75- to 79-year-olds; 0.62 (95% CI, 0.51-0.75) for 80- to 84-year-olds; and 0.45 (95% CI, 0.36-0.55) for ≥85-year-olds, as compared to 65- to 69-year-olds.

CONCLUSIONS

Asthma continues to affect a substantial proportion of the US elderly population. Increased diagnosis of COPD may overshadow correct diagnosis and treatment in populations with advancing age. Treatment guidelines should focus on preventable risk behaviors to increase the quality of life within this population.

摘要

目的

三十多年来,哮喘死亡的最大负担发生在65岁及以上人群中。本研究分析了美国老年人群中年龄增长与哮喘患病率之间的关联。

方法

我们分析了来自2001 - 2010年美国国家健康访谈调查(NHIS)的54485名65岁及以上美国非机构化平民成年人的汇总数据。我们按5岁年龄组和年龄阶段(65 - 84岁的“年轻老年人”和≥85岁的“最年长者”)估算了美国老年人中当前哮喘、终生哮喘和慢性阻塞性肺疾病(COPD)的患病率。我们计算了调整后的优势比(AOR)和95%置信区间(CI),以确定老年人群中的哮喘患病率模式。

结果

2001年至2010年,美国老年人中当前哮喘的估计年均患病率为7.0%。终生哮喘、COPD以及同时患有当前哮喘和COPD的估计患病率分别为9.9%、9.7%和3.0%。哮喘患病率随年龄增长而下降,而COPD患病率随年龄增长而上升。在控制研究变量以及与COPD的显著交互作用(p = 0.05)后,报告当前哮喘的几率随年龄增长而降低:70至74岁人群为0.87(95% CI,0.76 - 1.01);75至79岁人群为0.76(95% CI,0.66 - 0.87);80至84岁人群为0.62(95% CI,0.51 - 0.75);≥85岁人群为0.45(95% CI,0.36 - 0.55),与65至69岁人群相比。

结论

哮喘继续影响着相当比例的美国老年人群。COPD诊断增加可能掩盖了老年人群中正确的诊断和治疗。治疗指南应侧重于可预防的风险行为,以提高该人群的生活质量。

相似文献

1
Asthma prevalence among US elderly by age groups: age still matters.美国老年人按年龄组划分的哮喘患病率:年龄仍然很重要。
J Asthma. 2012 Aug;49(6):593-9. doi: 10.3109/02770903.2012.684252. Epub 2012 Jul 6.
2
Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.选定风险行为和慢性病及状况的流行率——步骤社区,美国,2006-2007 年。
MMWR Surveill Summ. 2010 Sep 24;59(8):1-37.
3
The risk of obstructive airways disease in a glaucoma population.青光眼患者群体中患阻塞性气道疾病的风险。
Pharmacoepidemiol Drug Saf. 2001 Mar-Apr;10(2):157-63. doi: 10.1002/pds.567.
4
Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.儿童哮喘与 GOLD 定义的慢性阻塞性肺疾病。
Intern Med J. 2012 Jan;42(1):83-8. doi: 10.1111/j.1445-5994.2010.02238.x. Epub 2010 Apr 12.
5
Dispensed volumes of anti-asthmatic drugs related to the prevalence of asthma and COPD in Sweden.瑞典与哮喘和慢性阻塞性肺疾病患病率相关的抗哮喘药物配给量。
Pharmacoepidemiol Drug Saf. 2008 May;17(5):461-7. doi: 10.1002/pds.1564.
6
Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference?通过健康访谈调查和全科医生登记得出的哮喘或慢性阻塞性肺疾病患病率估计值:有何差异?
Eur J Public Health. 2006 Feb;16(1):101-5. doi: 10.1093/eurpub/cki043. Epub 2005 Sep 1.
7
Prevalence of selected risk behaviors and chronic diseases--Behavioral Risk Factor Surveillance System (BRFSS), 39 steps communities, United States, 2005.特定风险行为和慢性病的患病率——行为风险因素监测系统(BRFSS),美国39个社区,2005年
MMWR Surveill Summ. 2008 Oct 31;57(11):1-20.
8
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.长期护理机构中医疗保险受益人的慢性阻塞性肺疾病负担
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
9
A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure.一项关于慢性阻塞性肺疾病流行病学及其与吸烟和环境烟草烟雾暴露关系的多中心研究。
Indian J Chest Dis Allied Sci. 2006 Jan-Mar;48(1):23-9.
10
Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.非吸烟者的气道阻塞:第三次全国健康与营养检查调查结果
Am J Med. 2005 Dec;118(12):1364-72. doi: 10.1016/j.amjmed.2005.06.041.

引用本文的文献

1
The Saudi initiative for asthma - 2024 update: Guidelines for the diagnosis and management of asthma in adults and children.沙特哮喘倡议 - 2024年更新版:成人及儿童哮喘诊断与管理指南
Ann Thorac Med. 2024 Jan-Mar;19(1):1-55. doi: 10.4103/atm.atm_248_23. Epub 2023 Dec 15.
2
Increasing the accuracy of the asthma diagnosis using an operational definition for asthma and a machine learning method.使用哮喘的操作性定义和机器学习方法提高哮喘诊断的准确性。
BMC Pulm Med. 2023 Jun 6;23(1):196. doi: 10.1186/s12890-023-02479-4.
3
Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study.
普通人群中的哮喘患病率及表型分析:LEAD(肺、心、社会、身体)研究
J Asthma Allergy. 2023 Apr 8;16:367-382. doi: 10.2147/JAA.S402326. eCollection 2023.
4
Asthma Care in the Elderly: Practical Guidance and Challenges for Clinical Management - A Framework of 5 "Ps".老年哮喘的护理:临床管理的实用指南与挑战——一个由5个“P”构成的框架
J Asthma Allergy. 2023 Jan 5;16:33-43. doi: 10.2147/JAA.S293081. eCollection 2023.
5
Association between lipid profiles and viral respiratory infections in human sputum samples.脂类谱与人类痰样本中病毒呼吸道感染的关联。
Respir Res. 2022 Jul 2;23(1):177. doi: 10.1186/s12931-022-02091-w.
6
[What not to do in the therapeutic management of bronchial asthma. Delphi consensus recommendations for physicians who treat asthma].[支气管哮喘治疗管理中不宜做的事。针对哮喘治疗医生的德尔菲共识推荐意见]
Aten Primaria. 2021 Aug-Sep;53(7):102101. doi: 10.1016/j.aprim.2021.102101. Epub 2021 May 21.
7
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics.年龄不影响抗IL-5/IL-5R治疗重症哮喘患者的疗效。
World Allergy Organ J. 2019 Nov 6;12(11):100081. doi: 10.1016/j.waojou.2019.100081. eCollection 2019 Nov.
8
A defined human aging phenome.一个明确的人类衰老表型组。
Aging (Albany NY). 2019 Aug 12;11(15):5786-5806. doi: 10.18632/aging.102166.
9
Reliability and usability of a weighted version of the Functional Comorbidity Index.功能合并症指数加权版本的可靠性和可用性。
Clin Interv Aging. 2019 Feb 11;14:289-299. doi: 10.2147/CIA.S185112. eCollection 2019.
10
The Contribution of Oxidative Stress and Inflamm-Aging in Human and Equine Asthma.氧化应激和炎症衰老在人类和马属动物哮喘中的作用。
Int J Mol Sci. 2017 Dec 5;18(12):2612. doi: 10.3390/ijms18122612.